{"database": "lobbying", "table": "lobbying_activities", "rows": [[1338518, "7df9cbcb-27fa-48cf-bf82-f79a91f6a23b", "Q4", "EMPIRE CONSULTING GROUP", 400703105, "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA", 2012, "fourth_quarter", "PHA", "\"Dual eligibles\" (Medicare-Medicaid) issues; and Medicare Prescription Drug Act issues; health disparities in minority communities; and issues relating to the Medicare Prescription Drug Act and the Patient Protection & Affordable Care Act.", "HOUSE OF REPRESENTATIVES", 30000, null, 0, 0, "2013-01-17T09:39:32.827000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1338518"], "units": {}, "query_ms": 0.342977000400424, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}